RxDoctor Payments DataLook up a doctor →

Paul Yamauchi, PhD

Dermatology · Santa Monica, CANPI 1720074537

Payments from drug & device makers

$7,846,224in general payments, 2019–2025

Across 4,877 payments — averaging $1608.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$914K
  • Amgen$890K
  • E.r. Squibb & Sons, L.L.C.$708K
  • Eli Lilly$694K
  • Lilly USA, LLC$522K
  • Pfizer$356K
  • plus $3.8M from 54 others
$31,143in research payments, 2019–2025

Across 10 payments — averaging $3114.31 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$19K
  • Novartis$12K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novartis227$914,246
Amgen(2 entities)377$889,952
E.r. Squibb & Sons, L.L.C.215$708,078
Eli Lilly56$694,117
Lilly USA, LLC534$521,803
Pfizer212$356,407
AbbVie(2 entities)452$332,338
Sun Pharmaceutical Industries Inc.213$277,610
Janssen Research & Development, LLC70$248,386
Incyte Corporation315$246,595
Sanofi US Services Inc.33$243,676
Sanofi208$242,749
Johnson & Johnson432$231,219
UCB SA10$214,174
UCB, Inc.270$169,600
Takeda Pharmaceuticals U.S.A., Inc.36$168,711
GSK20$143,554
Arcutis Biotherapeutics, Inc.104$130,955
Regeneron Healthcare Solutions, Inc.145$126,850
LEO Pharma AS24$117,334
Bristol Myers Squibb69$116,415
Janssen Scientific Affairs, LLC87$115,806
Dermavant Sciences, Inc.250$101,738
LEO Pharma Inc.139$98,877
Dr.reddy's Laboratories,inc.33$79,070
Boehringer Ingelheim23$62,457
Galderma Laboratories, L.p.85$51,839
UCB Biosciences Inc.2$35,982
Perrigo Company PLC1$28,250
Regeneron15$27,125
Almirall LLC32$25,515
Kowa Pharmaceuticals America, Inc.16$18,879
Dermira, Inc.11$16,401
AstraZeneca2$14,931
Organon17$9,770
EPI Health, LLC14$9,200
Padagis US LLC2$8,760
Argenx US, Inc.4$8,561
Vanda Pharmaceuticals Inc.5$7,986
Genentech, Inc.3$7,797
Galderma Research & Development, LLC5$4,029
Journey Medical Corporation1$3,500
Ortho Dermatologics, A Division Of Bausch Health US, LLC43$3,457
Boehringer Ingelheim Pharma GmbH & Co.kg1$3,158
Kyowa Kirin, Inc.5$2,878
Boehringer Ingelheim International GmbH1$1,500
Astrazeneca UK Limited1$1,198
Vertex3$920
Sanofi-aventis U.S. LLC10$345
Mayne Pharma Commercial LLC10$260
Botanix SB Inc6$200
Zydus Pharmaceuticals (USA) Inc.1$150
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC1$148
Revance Therapeutics, Inc.1$116
Genentech USA, Inc.4$109
Sandoz5$107
Glenmark Therapeutics Inc.1$90
ANI Pharmaceuticals, Inc.3$76
Aclaris Therapeutics, Inc.2$60
Fresenius Kabi USA, LLC2$41

How this compares

$7,846,224 in reported general payments places this provider in the 95th percentile of 1,875 dermatology providers in California.

See all dermatology providers in California →

Medicare billing

Part B allowed, 2024
$330,744
Medicare patients
530
Services billed
4,197

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other dermatology in Santa Monica

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →